Imagion Biosystems (ASX:IBX) reports “positive” first MagSense breast cancer clinical data
Imagion Biosystems (ASX:IBX) has reported evidence in human patients that its MagSense cancer detection technology could…
| Change | ||
| S&P/ASX Sm. Ords. | |||
| All Ordinaries | |||
| S&P/ASX 100 |
| T3D | 333D Limited | 3.5¢ | 40.0% |
| CUP | Count Ltd | $1.64 | 22.4% |
| LNQ | LinQ Minerals Ltd | 55.0¢ | 19.6% |
| DXN | DXN Limited | 15.0¢ | 43.4% |
| CYL | Catalyst Metals Limited | $3.99 | 23.4% |
| DAI | Decidr AI Industries Ltd | 22.0¢ | 22.8% |